Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sec1 family domain-containing protein 2 (SCFD2) is a protein involved in intracellular protein transport and vesicle-mediated trafficking processes, particularly in vesicle docking and fusion steps[1][3]. SCFD2 is predicted to interact with proteins involved in neurodevelopment and synaptic function, and is implicated in several biological processes across species, including cellular homeostasis and metabolism[2]. Elevated expression of SCFD2 is associated with a poorer prognosis in estrogen receptor-positive breast cancer, and functional studies indicate that SCFD2 supports tumor cell proliferation and endocrine therapy resistance, suggesting utility as a prognostic biomarker and a potential therapeutic target in cancer[1]. Furthermore, SCFD2 has emerging links to neurodevelopmental diseases, including autism and schizophrenia, where rare pathogenic alleles may contribute to susceptibility[2]. Its precise molecular function is still being elucidated, but its role in vesicle trafficking indicates involvement in fundamental cellular logistics[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sec1 family domain-containing protein 2 (SCFD2).